Cynosure Company Profile (NASDAQ:CYNO)

About Cynosure (NASDAQ:CYNO)

Cynosure logoCynosure, Inc. develops, manufactures and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve women's health. The Company also markets radiofrequency (RF), energy-sourced medical devices for surgical applications, such as facial plastic and general surgery, gynecology, ear, nose, and throat procedures, ophthalmology, oral and maxillofacial surgery, podiatry and proctology. The Company sells its products globally under the Cynosure, Palomar, ConBio and Ellman brand names. Its product portfolio includes single energy source systems, as well as workstations that incorporate two or more different types of lasers or light-based technologies.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:CYNO
  • CUSIP: 23257720
  • Web:
Average Prices:
  • 50 Day Moving Avg: $62.47
  • 200 Day Moving Avg: $50.89
  • 52 Week Range: $39.90 - $66.65
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 32.50
  • P/E Growth: 0.00
  • Net Margins: 0.70%
  • Return on Equity: 0.75%
  • Return on Assets: 0.59%
  • Debt-to-Equity Ratio: 0.04%
  • Current Ratio: 3.28%
  • Quick Ratio: 2.54%
  • Average Volume: 1.17 million shs.
  • Beta: 1.65

Frequently Asked Questions for Cynosure (NASDAQ:CYNO)

What is Cynosure's stock symbol?

Cynosure trades on the NASDAQ under the ticker symbol "CYNO."

How were Cynosure's earnings last quarter?

Cynosure, Inc. (NASDAQ:CYNO) released its earnings results on Tuesday, July, 26th. The company reported $0.36 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.29 by $0.07. The business had revenue of $110.30 million for the quarter, compared to analyst estimates of $101.31 million. Cynosure had a net margin of 0.70% and a return on equity of 0.75%. The business's revenue was up 31.8% on a year-over-year basis. During the same period last year, the company posted $0.30 EPS. View Cynosure's Earnings History.

Where is Cynosure's stock going? Where will Cynosure's stock price be in 2017?

7 analysts have issued 12-month price targets for Cynosure's shares. Their predictions range from $40.00 to $66.00. On average, they expect Cynosure's stock price to reach $58.33 in the next twelve months. View Analyst Ratings for Cynosure.

Who are some of Cynosure's key competitors?

How do I buy Cynosure stock?

Shares of Cynosure can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cynosure's stock price today?

One share of Cynosure stock can currently be purchased for approximately $65.97.

MarketBeat Community Rating for Cynosure (NASDAQ CYNO)
Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  219 (Vote Outperform)
Underperform Votes:  114 (Vote Underperform)
Total Votes:  333
MarketBeat's community ratings are surveys of what our community members think about Cynosure and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Cynosure (NASDAQ:CYNO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Hold Ratings, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $58.33 (11.58% downside)
Consensus Price Target History for Cynosure (NASDAQ:CYNO)
Price Target History for Cynosure (NASDAQ:CYNO)
Analysts' Ratings History for Cynosure (NASDAQ:CYNO)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
3/28/2017AegisReiterated RatingHold$66.00N/AView Rating Details
2/16/2017Northland SecuritiesReiterated RatingOutperform$60.00N/AView Rating Details
2/14/2017Northcoast ResearchUpgradeSell -> NeutralN/AView Rating Details
2/14/2017Maxim GroupDowngradeBuy -> Hold$66.00N/AView Rating Details
10/28/2016Leerink SwannReiterated RatingOutperform$63.00 -> $60.00N/AView Rating Details
10/26/2016Stifel NicolausReiterated RatingBuy$62.00 -> $58.00N/AView Rating Details
10/24/2016Brean CapitalReiterated RatingBuyN/AView Rating Details
(Data available from 10/23/2015 forward)


Earnings History for Cynosure (NASDAQ:CYNO)
Earnings by Quarter for Cynosure (NASDAQ:CYNO)
Earnings History by Quarter for Cynosure (NASDAQ CYNO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/7/2017Q416$0.41$0.44$119.97 million$122.10 millionViewListenView Earnings Details
10/25/2016Q316$0.28$0.29$101.11 million$106.40 millionViewListenView Earnings Details
7/26/2016Q216$0.29$0.36$101.31 million$110.30 millionViewListenView Earnings Details
4/26/2016Q116$0.14$0.19$85.78 million$94.70 millionViewListenView Earnings Details
2/9/2016Q415$0.36$0.42$95.01 million$102.40 millionViewListenView Earnings Details
10/27/2015Q315$0.18$0.21$76.68 million$78.40 millionViewListenView Earnings Details
7/28/2015Q215$0.27$0.30$82.71 million$83.70 millionViewListenView Earnings Details
5/5/2015Q1$0.17$0.15$70.87 million$74.90 millionViewListenView Earnings Details
2/10/2015Q414$0.39$0.36$83.01 million$86.30 millionViewListenView Earnings Details
10/28/2014Q314$0.24$0.25$69.94 million$71.50 millionViewListenView Earnings Details
7/29/2014Q214$0.30$0.32$71.15 million$72.60 millionViewListenView Earnings Details
5/6/2014Q1$0.23$0.19$64.70 million$62.00 millionViewListenView Earnings Details
2/12/2014Q413$0.19$0.39$67.80 million$74.50 millionViewListenView Earnings Details
10/29/2013Q313$0.19$0.23$61.60 million$60.70 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.20$0.29$46.96 million$50.09 millionViewListenView Earnings Details
4/30/2013Q1 2013$0.13$0.12$38.51 million$10.70 millionViewListenView Earnings Details
2/12/2013Q4 2012$0.23$0.27$40.98 million$47.70 millionViewListenView Earnings Details
10/23/2012$0.12$0.25ViewN/AView Earnings Details
7/24/2012$0.12$0.20ViewN/AView Earnings Details
5/1/2012($0.02)$0.06ViewN/AView Earnings Details
2/14/2012$0.05$0.08ViewN/AView Earnings Details
10/25/2011$0.04($0.06)ViewN/AView Earnings Details
5/3/2011($0.05)($0.15)ViewN/AView Earnings Details
2/15/2011($0.03)($0.06)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Cynosure (NASDAQ:CYNO)
2017 EPS Consensus Estimate: $1.63
2018 EPS Consensus Estimate: $2.02
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.23$0.26$0.24
Q2 20173$0.40$0.44$0.43
Q3 20173$0.38$0.42$0.40
Q4 20173$0.51$0.61$0.57
Q1 20181$0.34$0.34$0.34
Q2 20181$0.51$0.51$0.51
Q3 20181$0.50$0.50$0.50
Q4 20181$0.67$0.67$0.67
(Data provided by Zacks Investment Research)


Dividend History for Cynosure (NASDAQ:CYNO)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Cynosure (NASDAQ:CYNO)
Insider Ownership Percentage: 2.90%
Insider Trades by Quarter for Cynosure (NASDAQ:CYNO)
Institutional Ownership by Quarter for Cynosure (NASDAQ:CYNO)
Insider Trades by Quarter for Cynosure (NASDAQ:CYNO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/22/2016Douglas J DelaneyVPSell7,875$45.00$354,375.00View SEC Filing  
11/22/2016Michael R DavinChairmanSell16,284$45.00$732,780.00View SEC Filing  
8/30/2016Brian M BarefootDirectorSell21,000$51.66$1,084,860.00View SEC Filing  
8/15/2016Michael R DavinChairmanSell12,062$53.35$643,507.70View SEC Filing  
8/15/2016Timothy W BakerCFOSell5,834$53.35$311,243.90View SEC Filing  
8/11/2016Michael R DavinChairmanSell4,222$53.18$224,525.96View SEC Filing  
8/11/2016Timothy W BakerCFOSell2,041$53.19$108,560.79View SEC Filing  
5/13/2016Douglas J DelaneyVPSell12,299$46.60$573,133.40View SEC Filing  
5/13/2016Michael R DavinCEOSell26,271$46.59$1,223,965.89View SEC Filing  
5/13/2016Timothy W BakerCFOSell12,451$46.60$580,216.60View SEC Filing  
4/18/2016Douglas J DelaneyVPSell15,890$45.01$715,208.90View SEC Filing  
4/18/2016Michael R DavinCEOSell74,729$45.31$3,385,970.99View SEC Filing  
4/18/2016Timothy W BakerCFOSell14,008$45.02$630,640.16View SEC Filing  
4/14/2016Douglas J DelaneyVPSell24,488$45.02$1,102,449.76View SEC Filing  
4/14/2016Michael R DavinCEOSell61,377$45.01$2,762,578.77View SEC Filing  
4/14/2016Timothy W BakerCFOSell39,857$45.02$1,794,362.14View SEC Filing  
4/13/2016Michael R DavinCEOSell72$45.00$3,240.00View SEC Filing  
4/6/2016Douglas J DelaneyVPSell4,408$45.08$198,712.64View SEC Filing  
4/6/2016Michael R DavinCEOSell4,869$45.11$219,640.59View SEC Filing  
4/6/2016Timothy W BakerCFOSell4,413$45.08$198,938.04View SEC Filing  
4/4/2016Douglas J DelaneyVPSell66,626$45.47$3,029,484.22View SEC Filing  
4/4/2016Michael R DavinCEOSell66,259$45.61$3,022,072.99View SEC Filing  
4/4/2016Timothy W BakerCFOSell53,297$45.60$2,430,343.20View SEC Filing  
12/31/2015Michael R. DavinCEOSell200$45.00$9,000.00View SEC Filing  
12/31/2015Timothy W. BakerCFOSell100$45.00$4,500.00View SEC Filing  
6/1/2015Ettore V BiagioniDirectorSell24,000$36.25$870,000.00View SEC Filing  
5/20/2015Douglas J DelaneyVPSell89,000$38.01$3,382,890.00View SEC Filing  
5/20/2015Michael R DavinCEOSell151,000$38.07$5,748,570.00View SEC Filing  
4/23/2015Michael R DavinCEOSell6,991$33.04$230,982.64View SEC Filing  
4/10/2015Michael R DavinCEOSell44,677$33.01$1,474,787.77View SEC Filing  
4/9/2015Douglas J DelaneyVPSell28,335$33.01$935,338.35View SEC Filing  
4/9/2015Michael R DavinCEOSell70,000$32.00$2,240,000.00View SEC Filing  
4/8/2015Douglas J DelaneyVPSell45,000$32.00$1,440,000.00View SEC Filing  
1/9/2015Ettore V BiagioniDirectorSell12,000$30.09$361,080.00View SEC Filing  
12/2/2014Ettore V BiagioniDirectorSell2,500$28.00$70,000.00View SEC Filing  
11/24/2014Ettore V BiagioniDirectorSell5,000$27.28$136,400.00View SEC Filing  
11/5/2013Marina HatsopoulosDirectorBuy3,000$22.60$67,800.00View SEC Filing  
9/5/2012Douglas J DelaneyVPSell16,904$27.65$467,395.60View SEC Filing  
9/5/2012Michael R DavinCEOSell16,770$27.65$463,690.50View SEC Filing  
9/5/2012Timothy W BakerCFOSell16,854$27.65$466,013.10View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Cynosure (NASDAQ:CYNO)
Latest Headlines for Cynosure (NASDAQ:CYNO)
Loading headlines, please wait.



Cynosure (CYNO) Chart for Monday, October, 23, 2017

This page was last updated on 10/23/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.